Compare Oceana Therapeutics vs Ology Bioservices
Customers evaluate the quality of Oceana Therapeutics's products using the following success metrics.
Overview
Oceana Therapeutics is 16 yrs old and is based in United States.
Oceana Therapeutics is a specialty pharmaceutical company focused on commercializing late-stage and FDA-approved assets. In November 2011, Oceana Therapeutics was acquired by Salix Pharmaceuticals for $300 million in cash.
Ology Bioservices is 25 yrs old and is based in United States.
Ology Bioservices is a privately held biopharmaceutical company with a major focus on developing a diversified proprietary pipeline of products having both biodefense and medical applications. Products under development include biodefense medical countermeasures, CNS, wound healing, addiction and pain, oncology, anti-infectives, vaccines and orthopedics. The Company has one FDA cleared injectable biologic, NanoFUSE DBM, used by orthopedic surgeons as bone graft filler. Nanotherapeutics has in-house cGMP manufacturing, formulation, and expertise in pre-clinical and clinical product development as well as clinical trial management to support its products. On April 12th, 2021, Ology Bioservices was acquired by RESILIENCE. The terms of the transaction were not disclosed.
Demo Video
Leadership
Steven M. Bosacki (Senior Vice President)
Brandon Brega (Chief Operating Officer)
Investors
Salix Pharmaceuticals, New Enterprise Associates
Resilience, U.S. Department of Defense
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Oceana Therapeutics has not claimed their profile.
Work for Oceana Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Oceana Therapeutics?
Claim your profile now.
Information not available because Ology Bioservices has not claimed their profile.
Work for Ology Bioservices? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Ology Bioservices?
Claim your profile now.